Hot Drinks - Vietnam Euromonitor International : Country Market Insight March 2011 Hot Drinks Vietnam List of Contents and Tables Executive Summary .....................................................................................................................................................1 Healthy Growth Despite Global Economic Crisis ........................................................................................................1 Hectic Lifestyles Drive Demand
Premium Coffee
HOW DIFFERENT ARE BRANDING STRATEGIES IN THE PHARMACEUTICAL INDUSTRY VERSUS FAST MOVING CONSUMER GOODS? Abstract The objective of this paper is to analyse the branding strategies used currently in the pharmaceutical industry and compare it to the best practices in Fast Moving Consumer goods. First the authors review the differences in the way branding is defined and organised in pharmaceuticals versus FMCG and identify why branding could be leveraged in the pharmaceutical industry to help
Premium Brand Brand management Branding
CONTENT Question 1. Analyze the factors leading to Colgate Max Fresh’s success in the US market………………………………………………………………………………………..4 Question 2. Critically evaluate CMF’s adaptation strategies in China and Mexico. From a global CMF perspective‚ what are the short-term and long-term impacts of these adaptations?.............................................................................................................................6 Question 3. Suggest guidelines for optimizing new product
Premium Marketing Toothpaste Colgate-Palmolive
ACCT 3583 Syndicate Case Study Report Telstra Corporation Limited By BIG MAC Abilene Madeline Johan z3329202 Hui Melina Jarita z3357725 Lingbo Li z3346177 Li Chen z3326855 Xiaoyi Xu z3326452 Yinan Jia
Premium Strategic management
DELAWARE STATE UNIVERSITY (MBA – Spring 2011) Strategic Management Case Study Executive Summary: 3 Current Vision 4 Current Mission 4 Values 5 Current Strategies: 6 Developed Vision 7 Developed Mission 7 Reason for new mission 8 SWOT Analysis 9 External opportunities: 9 External Threats: 10 Financial and Operating Performance Analysis 11 Close Competitors 11 Ratio Analysis 11 Key Industry Ratios 14 Operating Profit margin
Premium Revenue Financial ratios Generic drug
An Epidemic of O besity Myths The Center for Consumer Freedom Obesity Myths.indd A1 11/29/2005 11:59:17 AM An Epidemic of Obesity Myths Obesity Myths.indd A5 11/29/2005 11:59:29 AM An Epidemic of Obesity Myths Obesity Myths.indd A7 11/29/2005 11:59:29 AM Copyright © 2005 by The Center for Consumer Freedom The Center for Consumer Freedom is a nonprofit coalition supported by restaurants‚ food companies‚ and consumers‚ working together to promote personal responsibility
Premium Obesity Body mass index
Corruption and its impact on Growth‚ Business and Government Effectiveness Ivo Dimovsky Managerial Economics – Empirical paper EMBA - American University of Bulgaria April 4th‚ 2012 ABSTRACT Corruption‚ like an infection‚ has co-existed with human society for a long time. Corruption has received significant attention among economists and international financial institutions during the last few decades‚ given its impact on economic growth both in developed and developing countries. There
Premium Political corruption Transparency International
RESEARCH TOPIC An In-depth-study of OTC medicine segment of Indian Pharmaceutical Industry with special emphasis on consumer behavior RESEARCH OBJECTIVES Macro objective To study the Indian Pharmaceutical Industry as a whole Micro objectives To understand the consumer’s attitude towards OTC products of the pharmaceutical industry To understand the healthcare products’ contribution and also its effects on pharmaceutical market To determine the extent to which the respondents prefer self-medication
Premium Pharmaceutical industry Pharmacology Generic drug
eSectoral Survey Pharmaceutical Industry in Egypt November 2010 Sectoral survey: Pharmaceutical Industry Index Page 1. Introduction 2. Definition 3. Regulatory framework 3.1.Regulatory body 3.2.Pricing 3.3.TRIPS 3 4 4 4. Market analysis 4.1.Market structure 4.2.Consumption 4.3.Production 4.4.Key players 7 5. Trade 5.1.Exports 5.2.Imports 5.3.Balance of trade 9 6. SWOT analysis 7. Outlook 8. Recommendations 9. Conclusion Appendix References 11 12 13 13 2
Premium Pharmacology Generic drug Food and Drug Administration
Contents Page 1. Introduction ........................................................................................................2 2. The stance of Pfizer ............................................................................................3 2.1 Theories of corporate social responsibility and ethics ...................................3 2.2 Pfizer ’s stance on CSR and ethics .........................................
Premium Business ethics Corporate social responsibility Social responsibility